OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Secukinumab provided significant and sustained improvement in the signs and symptoms of ankylosing spondylitis: results from the 52-week, Phase III China-centric study, MEASURE 5
Feng Huang, Fei Sun, Wei-Guo Wan, et al.
Chinese Medical Journal (2020) Vol. 133, Iss. 21, pp. 2521-2531
Open Access | Times Cited: 36
Feng Huang, Fei Sun, Wei-Guo Wan, et al.
Chinese Medical Journal (2020) Vol. 133, Iss. 21, pp. 2521-2531
Open Access | Times Cited: 36
Showing 1-25 of 36 citing articles:
Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis
Casper Webers, Augusta Ortolan, Alexandre Sepriano, et al.
Annals of the Rheumatic Diseases (2022) Vol. 82, Iss. 1, pp. 130-141
Open Access | Times Cited: 74
Casper Webers, Augusta Ortolan, Alexandre Sepriano, et al.
Annals of the Rheumatic Diseases (2022) Vol. 82, Iss. 1, pp. 130-141
Open Access | Times Cited: 74
Effect of Secukinumab Versus Adalimumab Biosimilar on Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: Results From a Head‐to‐Head Randomized Phase IIIb Study
Xenofon Baraliakos, Mikkel Østergaard, Denis Poddubnyy, et al.
Arthritis & Rheumatology (2024) Vol. 76, Iss. 8, pp. 1278-1287
Open Access | Times Cited: 14
Xenofon Baraliakos, Mikkel Østergaard, Denis Poddubnyy, et al.
Arthritis & Rheumatology (2024) Vol. 76, Iss. 8, pp. 1278-1287
Open Access | Times Cited: 14
Korean treatment recommendations for patients with axial spondyloarthritis
Mi Ryoung Seo, Jina Yeo, Jun Won Park, et al.
Journal of Rheumatic Diseases (2023) Vol. 30, Iss. 3, pp. 151-169
Open Access | Times Cited: 14
Mi Ryoung Seo, Jina Yeo, Jun Won Park, et al.
Journal of Rheumatic Diseases (2023) Vol. 30, Iss. 3, pp. 151-169
Open Access | Times Cited: 14
Efficacy and safety of IL inhibitors, TNF-α inhibitors, and JAK inhibitors in patients with ankylosing spondylitis: a systematic review and Bayesian network meta-analysis
Cong Tian, Jianlong Shu, Wenhui Shao, et al.
Annals of Translational Medicine (2023) Vol. 11, Iss. 4, pp. 178-178
Open Access | Times Cited: 13
Cong Tian, Jianlong Shu, Wenhui Shao, et al.
Annals of Translational Medicine (2023) Vol. 11, Iss. 4, pp. 178-178
Open Access | Times Cited: 13
Spectrum of Spondyloarthritis Among Chinese Populations
Shangzhu Zhang, Linyi Peng, Qingyang Li, et al.
Current Rheumatology Reports (2022) Vol. 24, Iss. 8, pp. 247-258
Open Access | Times Cited: 20
Shangzhu Zhang, Linyi Peng, Qingyang Li, et al.
Current Rheumatology Reports (2022) Vol. 24, Iss. 8, pp. 247-258
Open Access | Times Cited: 20
Long-Term Safety and Efficacy of Bimekizumab in Axial Spondyloarthritis: 2-Year Results from Two Phase 3 Studies
Xenofon Baraliakos, Atul Deodhar, Désirée van der Heijde, et al.
Lara D. Veeken (2025)
Closed Access
Xenofon Baraliakos, Atul Deodhar, Désirée van der Heijde, et al.
Lara D. Veeken (2025)
Closed Access
Risk of Cancers According to the Use of Biological Agents in Patients With Radiographic Axial Spondyloarthritis
Oh Chan Kwon, Hye Sun Lee, Juyeon Yang, et al.
JCR Journal of Clinical Rheumatology (2025)
Closed Access
Oh Chan Kwon, Hye Sun Lee, Juyeon Yang, et al.
JCR Journal of Clinical Rheumatology (2025)
Closed Access
Gastroenterological safety of IL-17 inhibitors: a systematic literature review
Bénédicte Caron, Jean‐Yves Jouzeau, Pierre Miossec, et al.
Expert Opinion on Drug Safety (2021) Vol. 21, Iss. 2, pp. 223-239
Closed Access | Times Cited: 23
Bénédicte Caron, Jean‐Yves Jouzeau, Pierre Miossec, et al.
Expert Opinion on Drug Safety (2021) Vol. 21, Iss. 2, pp. 223-239
Closed Access | Times Cited: 23
Incidence of infections in patients with psoriatic arthritis and axial spondyloarthritis treated with biological or targeted disease-modifying agents: a systematic review and meta-analysis of randomised controlled trials, open-label studies and observational studies
Mélanie Auréal, M. Seauve, Soline Laplane, et al.
RMD Open (2023) Vol. 9, Iss. 3, pp. e003064-e003064
Open Access | Times Cited: 8
Mélanie Auréal, M. Seauve, Soline Laplane, et al.
RMD Open (2023) Vol. 9, Iss. 3, pp. e003064-e003064
Open Access | Times Cited: 8
New developments in ankylosing spondylitis—status in 2021
Kalliopi Klavdianou, Styliani Tsiami, Xenofon Baraliakos
Lara D. Veeken (2021) Vol. 60, Iss. Supplement_6, pp. vi29-vi37
Open Access | Times Cited: 20
Kalliopi Klavdianou, Styliani Tsiami, Xenofon Baraliakos
Lara D. Veeken (2021) Vol. 60, Iss. Supplement_6, pp. vi29-vi37
Open Access | Times Cited: 20
Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life study
Roberta Ramonda, Mariagrazia Lorenzin, Maria Sole Chimenti, et al.
Therapeutic Advances in Musculoskeletal Disease (2022) Vol. 14
Open Access | Times Cited: 13
Roberta Ramonda, Mariagrazia Lorenzin, Maria Sole Chimenti, et al.
Therapeutic Advances in Musculoskeletal Disease (2022) Vol. 14
Open Access | Times Cited: 13
Using natural language processing to explore characteristics and management of patients with axial spondyloarthritis and psoriatic arthritis treated under real-world conditions in Spain: SpAINET study
Diego Benavent, Santiago Muñoz‐Fernández, Isabel de la Morena, et al.
Therapeutic Advances in Musculoskeletal Disease (2023) Vol. 15
Open Access | Times Cited: 6
Diego Benavent, Santiago Muñoz‐Fernández, Isabel de la Morena, et al.
Therapeutic Advances in Musculoskeletal Disease (2023) Vol. 15
Open Access | Times Cited: 6
Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial Spondyloarthritis
Walter P. Maksymowych, Howard Thom, Michael F. Mørup, et al.
Rheumatology and Therapy (2024) Vol. 11, Iss. 4, pp. 1023-1041
Open Access | Times Cited: 2
Walter P. Maksymowych, Howard Thom, Michael F. Mørup, et al.
Rheumatology and Therapy (2024) Vol. 11, Iss. 4, pp. 1023-1041
Open Access | Times Cited: 2
Secukinumab in axial spondyloarthritis: a narrative review of clinical evidence
J. Braun, Uta Kiltz, Björn Bühring, et al.
Therapeutic Advances in Musculoskeletal Disease (2021) Vol. 13
Open Access | Times Cited: 15
J. Braun, Uta Kiltz, Björn Bühring, et al.
Therapeutic Advances in Musculoskeletal Disease (2021) Vol. 13
Open Access | Times Cited: 15
A Pooled Analysis Reporting the Efficacy and Safety of Secukinumab in Male and Female Patients with Ankylosing Spondylitis
Irene van der Horst‐Bruinsma, Corinne Miceli‐Richard, J. Braun, et al.
Rheumatology and Therapy (2021) Vol. 8, Iss. 4, pp. 1775-1787
Open Access | Times Cited: 12
Irene van der Horst‐Bruinsma, Corinne Miceli‐Richard, J. Braun, et al.
Rheumatology and Therapy (2021) Vol. 8, Iss. 4, pp. 1775-1787
Open Access | Times Cited: 12
Anti-IL17 treatment in childhood chronic rheumatic diseases
Valerio Maniscalco, Ilaria Maccora, Flavio Girodo, et al.
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 5, pp. 429-441
Closed Access | Times Cited: 4
Valerio Maniscalco, Ilaria Maccora, Flavio Girodo, et al.
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 5, pp. 429-441
Closed Access | Times Cited: 4
Comparison of biologics and small-molecule drugs in axial spondyloarthritis: a systematic review and network meta-analysis
Erye Zhou, Jian Wu, Keqin Zeng, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Erye Zhou, Jian Wu, Keqin Zeng, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Incidence of Uveitis in Patients With Axial Spondylarthritis Treated With Biologics or Targeted Synthetics: A Systematic Review and Network Meta‐Analysis
Katie Bechman, Zijing Yang, Maryam Adas, et al.
Arthritis & Rheumatology (2023) Vol. 76, Iss. 5, pp. 704-714
Open Access | Times Cited: 4
Katie Bechman, Zijing Yang, Maryam Adas, et al.
Arthritis & Rheumatology (2023) Vol. 76, Iss. 5, pp. 704-714
Open Access | Times Cited: 4
Drug Survival, Effectiveness and Safety of Secukinumab in Axial Spondyloarthritis up to 4 Years: A Real-Life Single Center Experience
Alexandra-Diana Diaconu, Cristina Pomîrleanu, Mara Russu, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 4, pp. 417-417
Open Access | Times Cited: 1
Alexandra-Diana Diaconu, Cristina Pomîrleanu, Mara Russu, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 4, pp. 417-417
Open Access | Times Cited: 1
IL-17 inhibitors in axial spondyloarthritis. An overview
Éric Toussirot, Renaud Felten
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 9, pp. 917-932
Closed Access | Times Cited: 1
Éric Toussirot, Renaud Felten
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 9, pp. 917-932
Closed Access | Times Cited: 1
Evidence for the Use of Secukinumab in Patients with Radiographic and Non-radiographic Axial Spondyloarthritis in the Last 5 Years
M. Aparicio, Carlos Antonio Guillén Astete, Clementina López‐Medina, et al.
Rheumatology and Therapy (2021) Vol. 9, Iss. 1, pp. 73-94
Open Access | Times Cited: 8
M. Aparicio, Carlos Antonio Guillén Astete, Clementina López‐Medina, et al.
Rheumatology and Therapy (2021) Vol. 9, Iss. 1, pp. 73-94
Open Access | Times Cited: 8
Upadacitinib (Rinvoq)
CADTH
Canadian Journal of Health Technologies (2023) Vol. 3, Iss. 8
Open Access | Times Cited: 2
CADTH
Canadian Journal of Health Technologies (2023) Vol. 3, Iss. 8
Open Access | Times Cited: 2
<p>Impact of Secukinumab on Patient-Reported Outcomes in the Treatment of Ankylosing Spondylitis: Current Perspectives</p>
Hasan Tahir, Arumugam Moorthy, Antoni Chan
Open Access Rheumatology Research and Reviews (2020) Vol. Volume 12, pp. 277-292
Open Access | Times Cited: 5
Hasan Tahir, Arumugam Moorthy, Antoni Chan
Open Access Rheumatology Research and Reviews (2020) Vol. Volume 12, pp. 277-292
Open Access | Times Cited: 5
Oral Candida Infection in Psoriatic Patients Treated with IL17A Inhibitors: Report of 3 Cases and a Comprehensive Review of the Literature
Efstathios Pettas, Vasiliki Savva, Vasileios Ionas Theofilou, et al.
Diagnostics (2021) Vol. 12, Iss. 1, pp. 3-3
Open Access | Times Cited: 5
Efstathios Pettas, Vasiliki Savva, Vasileios Ionas Theofilou, et al.
Diagnostics (2021) Vol. 12, Iss. 1, pp. 3-3
Open Access | Times Cited: 5
Inflammatory Bowel Disease Risk in Patients With Axial Spondyloarthritis Treated With Biologic Agents Determined Using the BSRBR-AS and a MetaAnalysis
Gary J. Macfarlane, Renke Biallas, Linda E. Dean, et al.
The Journal of Rheumatology (2022) Vol. 50, Iss. 2, pp. 175-184
Open Access | Times Cited: 3
Gary J. Macfarlane, Renke Biallas, Linda E. Dean, et al.
The Journal of Rheumatology (2022) Vol. 50, Iss. 2, pp. 175-184
Open Access | Times Cited: 3
